Marshall Wace’s United States Antimony UAMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.75M Buy
1,205,386
+1,141,865
+1,798% +$10.3M 0.01% 1093
2026
Q1
$555K Buy
+63,521
New +$554K ﹤0.01% 2394
2025
Q3
– Sell
-598,817
Closed -$1.31M – 3423
2025
Q2
$1.31M Buy
598,817
+47,885
+9% +$136K ﹤0.01% 1745
2025
Q1
$1.21M Buy
550,932
+314,877
+133% +$546K ﹤0.01% 1700
2024
Q4
$418K Buy
236,055
+149,423
+172% +$150K ﹤0.01% 2114
2024
Q3
$65.8K Buy
+86,632
New +$43.5K ﹤0.01% 2406

Other funds holding UAMY

Marshall Wace's UAMY Position: Q2 2026 in Review

Marshall Wace increased its United States Antimony (UAMY) stake by 1,798% in Q2 2026, buying an estimated $10.3M and bringing the position to 1,205,386 shares worth $8.75M. The position accounts for 0.01% of the portfolio, ranked #1093.

Marshall Wace first reported a position in UAMY in Q3 2024 and has held it in 6 quarters since. 240 funds tracked by Wall St. Rank hold UAMY as of Q2 2026.

  • Marshall Wace held 1,205,386 shares of United States Antimony worth $8.75M as of Q2 2026.
  • Marshall Wace bought 1,141,865 United States Antimony shares in Q2 2026, an estimated $10.3M.
  • United States Antimony made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #1093 holding.
  • Marshall Wace first reported a position in United States Antimony in Q3 2024 and has held it in 6 quarters since.
  • 240 funds tracked by Wall St. Rank held United States Antimony as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.